Introduction Cardiac amyloidosis (CA) is a disease with a difficult diagnosis, limited management and a reserved prognosis., A high level of suspicion is necessary for its identification. There are some clinical clues, such as elderly individuals with unexplained left ventricular hypertrophy (LVH), heart failure with preserved ejection fraction (HFpEF) and restrictive pattern, dissociation between LVH on echocardiography and low voltage on the electrocardiogram, among others., CA can occur with several hemodynamic forms and patterns of remodeling, according to the disease […]